PKC-THETA MODULATORS

Disclosed are compounds, compositions and methods for treating disease, syndromes, conditions and disorders that are affected by the modulation of PKC-theta. Such compounds are represented by Formula I, wherein the variables are defined herein. (I) L'invention concerne des composés, des composi...

Full description

Saved in:
Bibliographic Details
Main Authors RAY, Peter, BESNARD, Jeremy, RICHARDS, Simon, MENEYROL, Jérôme, SANTOS, Catarina, SUCHAUD, Virginie, BRADLEY, Anthony
Format Patent
LanguageEnglish
French
Published 10.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds, compositions and methods for treating disease, syndromes, conditions and disorders that are affected by the modulation of PKC-theta. Such compounds are represented by Formula I, wherein the variables are defined herein. (I) L'invention concerne des composés, des compositions et des procédés pour traiter une maladie, des syndromes, des états et des troubles qui sont affectés par la modulation de PKC-thêta. De tels composés sont représentés par la formule I, dont les variables sont définies dans la description. (I)
Bibliography:Application Number: WO2022GB51166